CHA Biotech’s Third-Generation Hepatitis B Vaccine Shows Strong Results in Phase 1 Clinical Trial

CHA Vaccine Research Institute (CEO Yeom Jeong-seon), an affiliate of CHA Biotech, announced the Phase 1 Clinical Trial Result Report (CSR) results (key indicators) of China’s preventive hepatitis B vaccine on the 30th. third generation ‘CVI -HBV-002’. . The CHA Vaccine Research Institute received IND approval for national phase 1 clinical trials of the third-generation […]
The post CHA Biotech’s Third-Generation Hepatitis B Vaccine Shows Strong Results in Phase 1 Clinical Trial appeared first on News Directory 3.